ArticlePLOS digital health2025
AI modeling for outbreak prediction: A graph-neural-network approach for identifying vancomycin-resistant enterococcus carriers.
Article in PLOS digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Reimagining antimicrobial resistance: AI-driven predictive epidemiology and the C-AMRE framework for next-generation antibiotic discovery.The Journal of antibiotics · 2026Review
- Review
- Attention-based graph neural network framework for non-invasive CAP score prediction in fatty liver disease via body modeling.Physical and engineering sciences in medicine · 2026Article
- Vancomycin resistance in gram-positive infections: evolutionary strategies of survival.Archives of microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The isolation of affected patients and intensified infection control measures are used to prevent nosocomial transmission of vancomycin-resistant enterococci (VRE), but early detection of VRE carriers is needed. However, there are still no standard screening criteria for VRE, which poses a significant threat to patient safety. Our study aimed to develop and evaluate an artificial intelligence (AI)-based approach for identifying and predicting of at-risk patients who could assist infection prevention and control staff through a human-in-the-loop approach. We used data from 8,372 patients, combining more than 125,000 movements within our hospital with patient-related information to create time-dependent graph sequences and applied graph neural networks (GNNs) to classify patients as VRE carriers or noncarriers. Our model achieves a macro F1 score of 0.880 on the task (sensitivity of 0.808, specificity of 0.942). The parameters with the strongest impact on the prediction are the codes for clinical diagnosis (ICD) and operations/procedures (OPS), which are integrated as high-dimensional patient node features in our model. We demonstrate that modeling a "living" hospital with a GNN is a promising approach for the early detection of potential VRE carriers. This proves that AI-based tools combining heterogeneous information types can predict VRE carriage with high sensitivity and could therefore serve as a promising basis for future automated infection prevention control systems. Such systems could help enhance patient safety and proactively reduce nosocomial transmission events through targeted, cost-efficient interventions. Moreover, they could enable a more effective approach to managing antimicrobial resistance.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.